Steven D Rubin
Director · 6 filings · Latest: Jun 24, 2026
Eloxx Pharmaceuticals, Inc.
Entera Bio Ltd.
Niagen Bioscience, Inc.
Red Violet, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ELOX | Steven D Rubin | Director | Jan 24, 2026 | Option Exercise | — | 1,875 | — | 14,625 | |
[ENTX] | Steven D Rubin | Director | Feb 12, 2026 | Purchase | $1.49 | 5,000 | $7.5K | 15,000 | |
[ENTX] | Steven D Rubin | Director | Feb 9, 2026 | Purchase | $1.20 | 10,000 | $12.0K | 10,000 | |
RDVT | Rubin Steven D | — | Mar 19, 2025 | Proposed Sale | $38.93 | 10,000 | $389.3K | — |